Artificial intelligence has the potential to improve ophthalmology practices by streamlining documentation, enhancing ...

The phase 3 clinical trial is a randomized, double-blind, three-arm study comparing MELT-300, sublingual midazolam, and ...

On World Sight Day, leading experts in ophthalmology look at artificial intelligence and how it could impact diagnosing and ...

Ten of the institute's ophthalmologists will present their work in more than 20 sessions with a wide range of topics ...

MJH Life Sciences, parent company of Ophthalmology Times, has acquired The EnVision Summit. The meeting, held annually in ...

According to the company, the platform accompanies the launch of Qdata Retinitis Pigmentosa for life sciences and the ...

According to the company, a $68 million Series D financing is co-led by Arboretum Ventures and Johnson & Johnson Innovation – ...

Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...

Coordinated by the International Agency for the Prevention of Blindness under the Love Your Eyes campaign banner, World Sight ...

The award from the National Institutes of Health will enable a team of researchers to investigate Alzheimer and Parkinson ...

The donation will support the development of the Artificial Intelligence Innovation Center, a collaborative hub with a focus ...

In a study, a team of UCLA investigators detail a deep-learning model pre-trained on 2D scans that accurately predicts ...